Cargando…

Precision Oncology with Drugs Targeting the Replication Stress, ATR, and Schlafen 11

SIMPLE SUMMARY: Chemotherapeutic DNA-damaging agents targeting replication are widely used but predictive rationales for drug combinations and patient selection still need clinical definition. Here, we review cancer-associated replication stress (RepStress) and its genomic signature, and propose how...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Ukhyun, Murai, Yasuhisa, Takebe, Naoko, Thomas, Anish, Pommier, Yves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465591/ https://www.ncbi.nlm.nih.gov/pubmed/34572827 http://dx.doi.org/10.3390/cancers13184601

Ejemplares similares

Schlafen 11 expression in human acute leukemia cells with gain-of-function mutations in the interferon-JAK signaling pathway
por: Murai, Yasuhisa, et al.
Publicado: (2021)

SLFN11’s surveillance role in protein homeostasis
por: Murai, Yasuhisa, et al.
Publicado: (2022)

Structural, molecular, and functional insights into Schlafen proteins
por: Jo, Ukhyun, et al.
Publicado: (2022)

SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors
por: Jo, Ukhyun, et al.
Publicado: (2021)

Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents
por: Jo, Ukhyun, et al.
Publicado: (2021)

Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum‐based chemotherapy
por: Taniyama, Daiki, et al.
Publicado: (2021)

Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
por: Murai, Junko, et al.
Publicado: (2016)

Identification of Schlafen-11 as a Target of CD47 Signaling That Regulates Sensitivity to Ionizing Radiation and Topoisomerase Inhibitors
por: Kaur, Sukhbir, et al.
Publicado: (2019)

Human Schlafen 11 inhibits influenza A virus production
por: Jitobaom, Kunlakanya, et al.
Publicado: (2023)

Structural and biochemical characterization of Schlafen11 N-terminal domain
por: Hou, Pengjiao, et al.
Publicado: (2023)

Internetabhängige Jugendliche schlafen schlechter
por: Bach, Bianca
Publicado: (2021)

Replication-associated formation and repair of human topoisomerase IIIα cleavage complexes
por: Saha, Liton Kumar, et al.
Publicado: (2023)

The role of Schlafen 11 (SLFN11) as a predictive biomarker for targeting the DNA damage response
por: Coleman, Niamh, et al.
Publicado: (2020)

Awakening of SCHLAFEN 11 by immunohistochemistry: a new biomarker predicting response to chemotherapy
por: Buettner, Reinhard
Publicado: (2021)

Loss of Schlafen3 influences the expression levels of Schlafen family members in ileum, thymus, and spleen tissue
por: Vomhof-DeKrey, Emilie E., et al.
Publicado: (2020)

Schlafen family member 11 indicates favorable prognosis of patients with head and neck cancer following platinum-based chemoradiotherapy
por: Hamada, Seijiro, et al.
Publicado: (2023)

Schlafens Can Put Viruses to Sleep
por: Kim, Eui Tae, et al.
Publicado: (2022)

Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response
por: Willis, Sophie E., et al.
Publicado: (2021)

Non-human Primate Schlafen11 Inhibits Production of Both Host and Viral Proteins
por: Stabell, Alex C., et al.
Publicado: (2016)

ATR inhibition augments the efficacy of lurbinectedin in small‐cell lung cancer
por: Schultz, Christopher W, et al.
Publicado: (2023)

Macrophage Activation and Differentiation Signals Regulate Schlafen-4 Gene Expression: Evidence for Schlafen-4 as a Modulator of Myelopoiesis
por: van Zuylen, Wendy J., et al.
Publicado: (2011)

Schlafens: Emerging Proteins in Cancer Cell Biology
por: Al-Marsoummi, Sarmad, et al.
Publicado: (2021)

Structural and biochemical characterization of human Schlafen 5
por: Metzner, Felix J, et al.
Publicado: (2022)

Schlafen-5 inhibits LINE-1 retrotransposition
por: Ding, Jiwei, et al.
Publicado: (2023)

Can Schlafen 11 Help to Stratify Ovarian Cancer Patients Treated with DNA-Damaging Agents?
por: Bednarikova, Marketa, et al.
Publicado: (2022)

Increased Replication Stress Determines ATR Inhibitor Sensitivity in Neuroblastoma Cells
por: King, David, et al.
Publicado: (2021)

Vil-Cre specific Schlafen 3 knockout mice exhibit sex-specific differences in intestinal differentiation markers and Schlafen family members expression levels
por: Vomhof-DeKrey, Emilie E., et al.
Publicado: (2021)

Analysis of the Prognostic Potential of Schlafen 11, Programmed Death Ligand 1, and Redox Status in Colorectal Cancer Patients
por: Miladinov, Marko, et al.
Publicado: (2023)

piRNA processing by a trimeric Schlafen-domain nuclease
por: Podvalnaya, Nadezda, et al.
Publicado: (2023)

PCNA-Dependent Cleavage and Degradation of SDE2 Regulates Response to Replication Stress
por: Jo, Ukhyun, et al.
Publicado: (2016)

Schlafen2 mutation unravels a role for chronic ER stress in the loss of T cell quiescence
por: Omar, Ibrahim, et al.
Publicado: (2016)

ATR expands embryonic stem cell fate potential in response to replication stress
por: Atashpaz, Sina, et al.
Publicado: (2020)

ASPM promotes ATR-CHK1 activation and stabilizes stalled replication forks in response to replication stress
por: Wu, Xingxuan, et al.
Publicado: (2022)

Schlafen 1 Inhibits the Proliferation and Tube Formation of Endothelial Progenitor Cells
por: Kuang, Chun-yan, et al.
Publicado: (2014)

Schlafen 5 as a Novel Therapeutic Target in Pancreatic Ductal Adenocarcinoma
por: Fischietti, Mariafausta, et al.
Publicado: (2021)

Progress in investigating the relationship between Schlafen5 genes and malignant tumors
por: Tu, Teng, et al.
Publicado: (2023)

PIDD mediates the association of DNA-PKcs and ATR at stalled replication forks to facilitate the ATR signaling pathway
por: Lin, Yu-Fen, et al.
Publicado: (2018)

Wee1 is required to sustain ATR/Chk1 signaling upon replicative stress
por: Saini, Priyanka, et al.
Publicado: (2015)

TRLS-14. TARGETING REPLICATIVE STRESS IN BRAIN TUMORS BY COMBINING ATR AND PARP INHIBITION
por: Sarvode, Supriya, et al.
Publicado: (2023)

ADAR1 links R-loop homeostasis to ATR activation in replication stress response
por: Zhang, Biao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s4r0ha21njde5mk6ajb2n594as